Gufic Biosciences Limited (GUFICBIO.NS)
INR 450.25
(0.18%)
INR 450.25
(0.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.89 Billion INR | 11.73% |
| 2022 | 1.15 Billion INR | -10.67% |
| 2021 | 1.29 Billion INR | 90.83% |
| 2020 | 676.53 Million INR | 75.54% |
| 2019 | 385.39 Million INR | -6.78% |
| 2018 | 413.43 Million INR | 22.08% |
| 2017 | 338.65 Million INR | 94.63% |
| 2016 | 173.99 Million INR | 60.65% |
| 2015 | 108.3 Million INR | 78.59% |
| 2014 | 60.64 Million INR | 5.28% |
| 2013 | 57.6 Million INR | 15.89% |
| 2012 | 49.7 Million INR | 89.88% |
| 2011 | 26.17 Million INR | 10.43% |
| 2010 | 23.7 Million INR | 39.97% |
| 2009 | 16.93 Million INR | -1.4% |
| 2008 | 17.17 Million INR | 10.02% |
| 2007 | 15.61 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 314.74 Million INR | -2.6% |
| 2023 Q1 | 312.4 Million INR | 13.68% |
| 2023 Q4 | 323.13 Million INR | 0.0% |
| 2023 FY | 1.28 Billion INR | 11.73% |
| 2023 Q2 | 354.06 Million INR | 13.34% |
| 2023 Q3 | 323.13 Million INR | -8.74% |
| 2022 FY | 1.15 Billion INR | -10.67% |
| 2022 Q1 | 288.13 Million INR | 3.98% |
| 2022 Q2 | 288.66 Million INR | 0.18% |
| 2022 Q4 | 274.81 Million INR | -6.55% |
| 2022 Q3 | 294.07 Million INR | 1.87% |
| 2021 FY | 1.29 Billion INR | 90.83% |
| 2021 Q1 | 415.22 Million INR | 55.92% |
| 2021 Q2 | 316.32 Million INR | -23.82% |
| 2021 Q3 | 282.33 Million INR | -10.75% |
| 2021 Q4 | 277.11 Million INR | -1.85% |
| 2020 FY | 676.53 Million INR | 75.54% |
| 2020 Q2 | 231.45 Million INR | 904.69% |
| 2020 Q3 | 212.48 Million INR | -8.2% |
| 2020 Q4 | 266.3 Million INR | 25.33% |
| 2020 Q1 | -28.76 Million INR | -130.98% |
| 2019 Q1 | 109.36 Million INR | -8.44% |
| 2019 Q3 | 98.15 Million INR | 30.1% |
| 2019 Q4 | 92.85 Million INR | -5.4% |
| 2019 FY | 385.39 Million INR | -6.78% |
| 2019 Q2 | 75.44 Million INR | -31.02% |
| 2018 FY | 413.43 Million INR | 22.08% |
| 2018 Q4 | 119.45 Million INR | 9.47% |
| 2018 Q3 | 109.11 Million INR | -3.34% |
| 2018 Q2 | 112.88 Million INR | 37.15% |
| 2018 Q1 | 82.3 Million INR | 5.08% |
| 2017 FY | 338.65 Million INR | 94.63% |
| 2017 Q4 | 78.32 Million INR | -19.22% |
| 2017 Q3 | 96.95 Million INR | 30.07% |
| 2017 Q2 | 74.54 Million INR | 26.77% |
| 2017 Q1 | 58.79 Million INR | 11.53% |
| 2016 FY | 173.99 Million INR | 60.65% |
| 2016 Q3 | 43.67 Million INR | 3.43% |
| 2016 Q1 | 41.5 Million INR | 13.43% |
| 2016 Q2 | 42.22 Million INR | 1.74% |
| 2016 Q4 | 52.72 Million INR | 20.71% |
| 2015 FY | 108.3 Million INR | 78.59% |
| 2015 Q4 | 36.59 Million INR | 10.37% |
| 2015 Q3 | 33.15 Million INR | 27.17% |
| 2015 Q2 | 26.06 Million INR | 61.92% |
| 2015 Q1 | 16.1 Million INR | 199.26% |
| 2014 Q4 | 5.38 Million INR | -60.35% |
| 2014 Q3 | 13.56 Million INR | -31.77% |
| 2014 FY | 60.64 Million INR | 5.28% |
| 2014 Q2 | 19.88 Million INR | -8.82% |
| 2014 Q1 | 21.81 Million INR | 48.06% |
| 2013 Q1 | 12.25 Million INR | 28.22% |
| 2013 FY | 57.6 Million INR | 15.89% |
| 2013 Q2 | 15.05 Million INR | 22.84% |
| 2013 Q4 | 14.73 Million INR | -5.31% |
| 2013 Q3 | 15.55 Million INR | 3.33% |
| 2012 Q4 | 9.55 Million INR | -26.75% |
| 2012 Q2 | 13.61 Million INR | 0.94% |
| 2012 Q3 | 13.05 Million INR | -4.13% |
| 2012 Q1 | 13.48 Million INR | 258.26% |
| 2012 FY | 49.7 Million INR | 89.88% |
| 2011 Q3 | 6.28 Million INR | 0.0% |
| 2011 Q4 | 3.76 Million INR | -40.13% |
| 2011 FY | 26.17 Million INR | 10.43% |
| 2010 FY | 23.7 Million INR | 39.97% |
| 2009 FY | 16.93 Million INR | -1.4% |
| 2008 FY | 17.17 Million INR | 10.02% |
| 2007 FY | 15.61 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -96.337% |
| Ind-Swift Limited | 1.22 Billion INR | -136.043% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -484.01% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 97.231% |
| Innova Captab Limited | 2.53 Billion INR | -14.226% |
| Divi's Laboratories Limited | 18.31 Billion INR | 84.195% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 35.318% |
| Morepen Laboratories Limited | 4.17 Billion INR | 30.668% |
| Mankind Pharma Limited | 40.86 Billion INR | 92.919% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -69.505% |
| Laurus Labs Limited | 3.94 Billion INR | 26.713% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 25.62% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 67.772% |
| Alembic Limited | 767.77 Million INR | -276.91% |
| Hikal Limited | 1.49 Billion INR | -93.669% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 49.744% |
| Neuland Laboratories Limited | 5.31 Billion INR | 45.586% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 61.629% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 55.496% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 41.447% |
| Themis Medicare Limited | 1.3 Billion INR | -122.07% |
| RPG Life Sciences Limited | 2.29 Billion INR | -26.24% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 93.625% |
| Lupin Limited | 27.75 Billion INR | 89.575% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -365.971% |
| Wockhardt Limited | 140 Million INR | -1967.003% |
| Vaishali Pharma Limited | 6.29 Million INR | -45877.185% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 7.491% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -1251.992% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 44.232% |
| FDC Limited | 3.03 Billion INR | 4.613% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 95.727% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -1290.918% |
| Eris Lifesciences Limited | 5.18 Billion INR | 44.154% |
| Venus Remedies Limited | 534.65 Million INR | -441.251% |
| ZIM Laboratories Limited | 1.09 Billion INR | -163.525% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -135.077% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -424.63% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 59.949% |
| Shilpa Medicare Limited | 3.76 Billion INR | 23.069% |
| Albert David Limited | 1.33 Billion INR | -116.853% |
| Ajanta Pharma Limited | 19.67 Billion INR | 85.294% |
| Hester Biosciences Limited | 364.77 Million INR | -693.323% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 37.196% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 175.107% |
| Windlas Biotech Limited | 1.29 Billion INR | -122.791% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -3.869% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -102124.722% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -10439.02% |
| Granules India Limited | 6.52 Billion INR | 55.673% |
| Aarti Drugs Limited | 7.14 Billion INR | 59.52% |
| Bal Pharma Limited | 214.56 Million INR | -1248.659% |
| Alkem Laboratories Limited | 19.46 Billion INR | 85.131% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 97.226% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -51.8% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -1117.618% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -13909.508% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -22.563% |
| Medico Remedies Limited | 277.11 Million INR | -944.25% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -44.04% |
| Ipca Laboratories Limited | 29.59 Billion INR | 90.222% |
| Brooks Laboratories Limited | -72.25 Million INR | 4105.154% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1061.0% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 88.578% |
| NATCO Pharma Limited | 25.96 Billion INR | 88.854% |
| Suven Life Sciences Limited | -1.22 Billion INR | 336.07% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 44.625% |
| Indoco Remedies Limited | 1.52 Billion INR | -89.832% |
| Alpa Laboratories Limited | 61.51 Million INR | -4604.225% |
| Lasa Supergenerics Limited | -458 Million INR | 731.828% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 170.323% |